| |
|
MethylGene Inc. |
|
MethylGene Inc., a biopharmaceutical company seeking treatment for cancer and infectious diseases, completed a bought deal financing with an underwriting syndicate led by Canaccord Capital Corporation Details |
|
2007 |
|
| |
|
S. Rossy Inc. and Dollar A.M.A. Inc. |
|
Dollarama L.P. acquired a majority position in the Dollarama business of Montreal-based S. Rossy Inc. and Dollar A.M.A. Inc., with the founders and management retaining a substantial stake. Dollarama is the largest dollar store network in Canada ... Details |
|
2004 |
|
| |
|
MethylGene Inc. |
|
MethylGene Inc. entered into of a Collaborative Research, Development and Commercialization Agreement for its histone deacetylase (HDAC) inhibitors with Pharmion Corporation in North America, Europe, the Middle East and certain other markets. Details |
|
2006 |
|
| |
|
SS&C Technologies, Inc. |
|
SS&C Technologies, Inc. acquired Financial Models Company Inc. for approximately CDN$207 million pursuant to an all-cash take-over bid. Details |
|
2005 |
|
| |
|
Neurochem Inc. |
|
Neurochem Inc. completed a public offering of 4 million common shares in the U.S. and in Canada, resulting in gross proceeds to the company of US$61.2 million. Details |
|
2005 |
|
| |
|
MethylGene Inc. |
|
MethylGene Inc., a biopharmaceutical company seeking treatment for cancer and infectious diseases, completed its initial public offering for gross proceeds of $ 21,632,500. Details |
|
2004 |
|
| |
|
Adaltis Inc. |
|
Adaltis Inc. completed an initial public offering of 10 million common shares at $5.50 per share for aggregate gross proceeds of CDN$55 million. Details |
|
2004 |
|
| |
|
PainCeptor Pharma Corporation |
|
PainCeptor Pharma Corporation, a new leading-edge biopharmaceutical company focused on novel and effective therapeutic drugs for the treatment of acute and chronic pain, successfully completed a Cdn$23 million initial private placement. Details |
|
2004 |
|
| |
|
Neurochem Inc. |
|
Public offering in the U.S. and Canada of $62 million of common shares of Neurochem Inc. Details |
|
2003 |
|
| |
|
CryoCath Technologies Inc. |
|
Purchase by CryoCath Technologies Inc. of Endocare, Inc.'s cardiac-related product manufacturing operations and related intellectual property. Details |
|
2003 |
|
